Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept-based corticosteroid-free regimens in de novo renal transplant
2006-003114-17Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of belatacept in kidney transplant immunosuppression (3 arms), sponsored by Bristol Myers Squibb. Started May 2007; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on 2006-003114-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003114-17.